31.83
price up icon4.57%   1.39
after-market Handel nachbörslich: 31.60 -0.23 -0.72%
loading

Travere Therapeutics Inc Aktie (TVTX) Neueste Nachrichten

pulisher
04:07 AM

Travere Therapeutics (TVTX) seeks approval to add 3M shares to 2018 equity plan - stocktitan.net

04:07 AM
pulisher
04:06 AM

[144] Travere Therapeutics, Inc. SEC Filing - stocktitan.net

04:06 AM
pulisher
01:28 AM

Travere Therapeutics (NASDAQ:TVTX) Shares Up 7.7%Still a Buy? - marketbeat.com

01:28 AM
pulisher
01:26 AM

Travere Therapeutics (TVTX) Stock Rises Over 9% in Market Sessio - GuruFocus

01:26 AM
pulisher
10:42 AM

Travere Therapeutics (TVTX) Stock Rises Over 9% in Market Session - gurufocus.com

10:42 AM
pulisher
Apr 05, 2026

TD Cowen Maintains Travere Therapeutics (TVTX) Buy Recommendation - MSN

Apr 05, 2026
pulisher
Apr 05, 2026

Buyback Watch: Is Travere Therapeutics Inc trading at a discount2026 Macro Moves & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

Palisades Investment Partners LLC Invests $5.26 Million in Travere Therapeutics, Inc. $TVTX - marketbeat.com

Apr 04, 2026
pulisher
Apr 02, 2026

Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 60,000 Shares - marketbeat.com

Apr 02, 2026
pulisher
Apr 02, 2026

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $300,000.00 in Stock - marketbeat.com

Apr 02, 2026
pulisher
Apr 02, 2026

Travere therapeutics CEO Dube sells $1.8m in TVTX stock By Investing.com - Investing.com Canada

Apr 02, 2026
pulisher
Apr 02, 2026

Travere therapeutics chief legal officer sells $300k in TVTX stock - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Travere therapeutics chief legal officer sells $300k in TVTX stock By Investing.com - Investing.com Australia

Apr 02, 2026
pulisher
Apr 02, 2026

Travere Therapeutics (TVTX) CEO sells 60K shares after option exercise - stocktitan.net

Apr 02, 2026
pulisher
Apr 02, 2026

Travere (NASDAQ: TVTX) CLO exercises options, pre-planned sale of 10K shares - stocktitan.net

Apr 02, 2026
pulisher
Apr 02, 2026

Travere Awaits FDA FILSPARI Ruling As Valuation Gap Draws Attention - Yahoo Finance

Apr 02, 2026
pulisher
Apr 01, 2026

(TVTX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Apr 01, 2026
pulisher
Apr 01, 2026

TVTX (NASDAQ: TVTX) files Form 144 for 60,000-share sale - stocktitan.net

Apr 01, 2026
pulisher
Apr 01, 2026

Elizabeth Reed registers sale of 10,000 TVTX shares (TVTX) via option exercise - stocktitan.net

Apr 01, 2026
pulisher
Mar 31, 2026

Hennion & Walsh Asset Management Inc. Increases Position in Travere Therapeutics, Inc. $TVTX - marketbeat.com

Mar 31, 2026
pulisher
Mar 30, 2026

A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Pullback - simplywall.st

Mar 30, 2026
pulisher
Mar 29, 2026

Tudor Investment Corp Cuts Stake in Travere Therapeutics - National Today

Mar 29, 2026
pulisher
Mar 29, 2026

Tudor Investment Corp ET AL Cuts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat

Mar 29, 2026
pulisher
Mar 28, 2026

Travere, CSL gets standard EU approval for kidney disorder treatment - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

JPMorgan Chase Cuts Travere Therapeutics Price Target - National Today

Mar 28, 2026
pulisher
Mar 27, 2026

Vanguard disaggregates holdings; reports 0 TVTX shares (Vanguard) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Travere Therapeutics, Inc. $TVTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat

Mar 27, 2026
pulisher
Mar 26, 2026

J.P. Morgan Gives a Buy Rating to Travere Therapeutics (TVTX) - The Globe and Mail

Mar 26, 2026
pulisher
Mar 26, 2026

Aug Spikes: Should value investors consider Travere Therapeutics Inc2026 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Travere Therapeutics price target lowered to $41 from $44 at JPMorgan - TipRanks

Mar 25, 2026
pulisher
Mar 25, 2026

Earnings Risk: Is Cayson Acquisition Corp Equity Right stock a falling knife or bargain buy2026 Volatility Report & High Accuracy Swing Trade Signals - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

FOMO Trade: Is Snail Inc forming bullish engulfing patternsMarket Trend Review & Weekly Top Gainers Trade List - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

JPMorgan Chase & Co. Has Lowered Expectations for Travere Therapeutics (NASDAQ:TVTX) Stock Price - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

JP Morgan Lowers Price Target for TVTX to $41.00, Maintains Over - GuruFocus

Mar 25, 2026
pulisher
Mar 25, 2026

Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 25, 2026
pulisher
Mar 23, 2026

Travere Therapeutics (TVTX) Gains Attention with Potential FDA A - GuruFocus

Mar 23, 2026
pulisher
Mar 23, 2026

Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics - TipRanks

Mar 23, 2026
pulisher
Mar 23, 2026

Citi Lifts Travere Therapeutics (TVTX) PT to $34 on Strong Q2 and Upcoming FDA Catalysts - MSN

Mar 23, 2026
pulisher
Mar 22, 2026

A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Volatility - simplywall.st

Mar 22, 2026
pulisher
Mar 21, 2026

Travere Therapeutics (TVTX) reports 144% annual growth in Filspari sales for 2025 - MSN

Mar 21, 2026
pulisher
Mar 21, 2026

Responsive Playbooks and the TVTX Inflection - Stock Traders Daily

Mar 21, 2026
pulisher
Mar 21, 2026

Travere Therapeutics, Inc. (TVTX) positioned for long-term growth in rare disease market - MSN

Mar 21, 2026
pulisher
Mar 20, 2026

Highs Report: Can Travere Therapeutics Inc be recession proofShare Buyback & Growth Focused Investment Plans - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 19, 2026

Is Travere Therapeutics (TVTX) Pricing Signal An Opportunity After Recent Share Price Pullback? - simplywall.st

Mar 19, 2026
pulisher
Mar 19, 2026

Travere Therapeutics Inc SEC Filings - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

TVTX Earnings History & Surprises | EPS & Revenue Results | TRAVERE THERAPEUTICS INC (NASDAQ:TVTX) - ChartMill

Mar 19, 2026
pulisher
Mar 18, 2026

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $280,900.00 in Stock - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Travere Therapeutics (TVTX) CLO exercises options and sells 10K shares - Stock Titan

Mar 18, 2026
pulisher
Mar 17, 2026

HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

Cinctive Capital Management LP Makes New $2.26 Million Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Earnings Recap: Is Travere Therapeutics Inc stock heavily shorted2026 Technical Patterns & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Mar 17, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):